Two of the identified FGFR fusions, FGFR3-TACC3 and FGFR2-KIAA1598, were initially reported in earlier profiling studies of cholangiocarcinoma, GBM, and pediatric low-grade glioma [16, 18, 39, 48]. This evidence concerns the gene SHTN1 and low grade glioma.